11Apr

[Comment] Chromosomal deletion at 22q11.2 and Parkinson’s disease

Chromosome 22q11.2 deletion syndrome is a group of heterogeneous disorders characterised by a deletion near the middle of chromosome 22 at a location designated q11.2. The clinical phenotype varies widely, with multiple system involvement. Well-recognised features include cleft palate, dysmorphic facial features, cardiac defects, skeletal deformities, developmental delays, and learning disabilities.1 Many affected people are identified at a young age. These patients are at an increased risk of developing schizophrenia and other mental disorders, and have a reduced lifespan.

Ander nieuws

20May

[Comment] A new step towards targeting tau

Progressive supranuclear palsy is a rare neurodegenerative disease characterised by an axial parkins...

naar nieuwsitem

20May

[Review] CSF and blood biomarkers for Parkinson’s disease

In the management of Parkinson's disease, reliable diagnostic and prognostic biomarkers are urg...

naar nieuwsitem

22Apr

Parkinson’s disease patient: ‘I can walk… it’s really helped me’

Parkinson's disease patient Gail Jardine can walk more freely after having a spinal implant fit...

naar nieuwsitem